SUMO family Ubiquitin-like Modifiers In Higher Eukaryotes

高等真核生物中的 SUMO 家族泛素样修饰剂

基本信息

项目摘要

SUMO proteins are a family of ubiquitin-related proteins that become covalently linked to other cellular proteins. While budding yeast has a single SUMO, called Smt3p, there are three commonly expressed mammalian SUMO paralogues, called SUMO-1, -2 and -3. SUMO-2 and -3 are 96% identical, while SUMO-1 is roughly 45% identical to either SUMO-2 or -3. In this report, SUMO-2 and -3 will be collectively called SUMO-2/3 under circumstances where they cannot be distinguished from each other. The individual functions of vertebrate SUMO paralogues are poorly understood: SUMO-1 is less abundant than SUMO-2/3, and it is conjugated to a distinct spectrum of targets. SUMO-1 also has different in vivo dynamics and responses to physiological stress such as heat shock. Unlike SUMO-2/3, SUMO-1 is concentrated at nuclear pore complexes (NPCs), the primary conduit of nucleocytoplasmic trafficking, reflecting the fact that it is the preferred conjugation partner of RanGAP1. RanGAP1 is the GTPase activator for Ran, a small GTPase that controls nuclear transport. SUMO-1 conjugation of RanGAP1 promotes its stable association to the NPCs through binding to a large nucleoporin, Nup358/RanBP2. Human SUMO proteins have been implicated in a variety of cell functions, including nuclear trafficking, chromosome segregation, chromatin organization, transcription and RNA metabolism. The conjugation pathway for SUMO proteins is similar to the ubiquitin conjugation pathway: SUMO proteins are processed by Ubiquitin like proteases/Sentrin specific proteases (Ulps/SENPs) to reveal a di-glycine motif at their C-termini. After processing, SUMO proteins undergo ATP-dependent formation of a thioester bond to their activating (E1) enzyme, Aos1/Uba2. The activated SUMO proteins are transferred to form a thioester linkage with their conjugating (E2) enzyme, Ubc9. Finally, an isopeptide bond is formed between SUMO proteins and substrates through the cooperative action of Ubc9 and protein ligases (E3). The linkage of SUMO proteins to their substrates can be severed by Ulps/SENPs, so it is likely that SUMO modification is highly dynamic in vivo. Ulp/SENPs play an important role in determination of the spectrum of conjugated species because they directly regulate the production of free, conjugatable SUMO proteins and the half-life of conjugated species. There are six members of the Ulp/SENP family in mammals and five in amphibians (Xenopus laevis). We are systematically evaluating the physiological roles and regulation of these enzymes. We have found that two Ulp/SENP family members, SENP3 and SENP5, localize within the granular component of the nucleolus, a sub-nucleolar compartment that contains B23/Nucleophosmin. B23/Nucleophosmin is an abundant shuttling phosphoprotein, which plays important roles in ribosome biogenesis, and which has been strongly implicated in hematopoietic malignancies. Moreover, we found that B23/Nucleophosmin binds SENP3 and SENP5 in Xenopus egg extracts, and that B23/Nucleophosmin promotes the stability of SENP3 and SENP5 in mammalian tissue culture cells. After either co-depletion of SENP3 and SENP5 or depletion of B23/Nucleophosmin, we observe accumulation of SUMO proteins within nucleoli. Finally, depletion of these Ulp/SENPs causes defects in ribosome biogenesis reminiscent of phenotypes observed in the absence of B23/Nucleophosmin. Together, these results suggest that regulation of SUMO deconjugation may be a major facet of B23/Nucleophosmin function in vivo. We are currently working to understand how SUMOylation contributes toward ribosome biogenesis through examination of SENP3 and SENP5 regulation, as well as through the identification of ribosomal SUMOylation targets. We had previously shown that SENP6 (also called SUSP1) localizes within the nucleoplasm, where it plays a specialized role in dismantling highly conjugated SUMO-2 and -3 species. This function is similar to the chain-editing activity of SENP6s closest relative in budding yeast, Ulp2. We have examined the role of SENP6 in chromosome segregation, a process that requires Ulp2p in yeast. We find that siRNA-mediated knockdown of SENP6 in HeLa cells leads to chromosome misalignment. This phenotype is accompanied by defects in spindle assembly and mitotic progression. To understand the underlying molecular defect, we have systematically evaluated the behavior of kinetochore-associated proteins, particularly those found to be SUMOylated in other contexts. We find both microtubule-dependent and microtubule-independent changes in kinetochore composition, and are currently working to establish whether these alterations can be directly linked to the modification of individual kinetochore proteins.
SUMO蛋白是一个泛素相关蛋白家族,与其他细胞蛋白共价连接。虽然出芽酵母有一个单一的SUMO,称为Smt3p,但有三个常见的哺乳动物SUMO同源物,称为SUMO-1, -2和-3。SUMO-2和-3有96%相同,而SUMO-1与SUMO-2或-3的相似度约为45%。在本报告中,SUMO-2和-3在无法区分的情况下统称为SUMO-2/3。脊椎动物的SUMO旁系物的单个功能尚不清楚:SUMO-1比SUMO-2/3更少,并且它共轭到不同的靶标光谱。SUMO-1还具有不同的体内动力学和对热休克等生理应激的反应。与SUMO-2/3不同,SUMO-1集中在核孔复合物(npc)上,这是核胞质运输的主要通道,反映了它是RanGAP1的首选偶联伙伴。RanGAP1是Ran的GTPase激活剂,Ran是一种控制核转运的小GTPase。SUMO-1偶联RanGAP1通过结合一个大核孔蛋白Nup358/RanBP2促进其与npc的稳定结合。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles.
SUMO-1靶向rangap1靶向动力学和有丝分裂纺锤体。
  • DOI:
    10.1083/jcb.200110109
  • 发表时间:
    2002-02-18
  • 期刊:
  • 影响因子:
    7.8
  • 作者:
    Joseph, Jomon;Tan, Shyh-Han;Karpova, Tatiana S;McNally, James G;Dasso, Mary
  • 通讯作者:
    Dasso, Mary
Special-interest subgroups at the ASCB: Are there multiple roles for the Ran GTPase?
ASCB 的特殊利益小组:Ran GTPase 是否有多种角色?
  • DOI:
    10.1016/s0962-8924(99)01500-7
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    19
  • 作者:
    Dasso,M
  • 通讯作者:
    Dasso,M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY C. DASSO其他文献

MARY C. DASSO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY C. DASSO', 18)}}的其他基金

1 Z01 HD008740-05 LGRD
1 Z01 HD008740-05 LGRD
  • 批准号:
    7334118
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Regulation of Mitotic Kinetochores by the Ran GTPase
Ran GTPase 对有丝分裂着丝粒的调节
  • 批准号:
    8351167
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Regulation of Mitotic Kinetochores by the Ran GTPase
Ran GTPase 对有丝分裂着丝粒的调节
  • 批准号:
    8553902
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Mitotic roles of the Nuclear Transport Machinery
核运输机械的有丝分裂作用
  • 批准号:
    10915324
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Mitotic Roles Of Ran GTPase
Ran GTPase 的有丝分裂作用
  • 批准号:
    6993681
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Mitotic Roles Of Ran GTPase
Ran GTPase 的有丝分裂作用
  • 批准号:
    6813963
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Regulation of Mitotic Kinetochores by the Ran GTPase
Ran GTPase 对有丝分裂着丝粒的调节
  • 批准号:
    8941484
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Mitotic roles of the Nuclear Transport Machinery
核运输机械的有丝分裂作用
  • 批准号:
    10267570
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Regulation of Mitotic Kinetochores by the Ran GTPase
Ran GTPase 对有丝分裂着丝粒的调节
  • 批准号:
    8149305
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:
Analysis Of The S Phase Checkpoint In Higher Eukaryotes
高等真核生物 S 期检查点的分析
  • 批准号:
    6541235
  • 财政年份:
  • 资助金额:
    $ 64.89万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 64.89万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 64.89万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 64.89万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 64.89万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 64.89万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 64.89万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 64.89万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 64.89万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 64.89万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 64.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了